Ann: Investor Presentation, page-25

Again, I'm only hoping we get some sort of announcement on the following;

• COVID-19 sdr is Genetic Technology’s COVID-19 Response – a low-cost, accurate assessment tool that

is designed to assist in pandemic management in lieu of a vaccine, It is the world’s first genomic test to predict the risk of hospitalization and of developing life-threatening complications, should the patient contract COVID-19

This was in BETA testing in Q3, and is being fast tracked for development and anticipate a market release early Q4...

I haven't seen any update/news on how the world-first polygenic risk test for colorectal and breast cancer is going? the communication is pretty poor, such great programs.